A. E. Kayl

Chemotherapy and Cognition: Effects, Potential Mechanisms, and Management

C. Meyers, J. Wefel, A. E. Kayl, 2006, American journal of therapeutics.

Neurocognitive Function

C. Meyers, A. E. Kayl, 2002 .

Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target

C. Meyers, J. Wefel, A. E. Kayl, 2004 .

Behavioral phenotype of neurofibromatosis, type 1.

B. Moore, A. E. Kayl, Bartlett D. Moore, 2000, Mental retardation and developmental disabilities research reviews.

Neuropsychological assessment of adults with cancer

R. Collins, J. Wefel, A. E. Kayl, 2008 .

Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients

C. Meyers, A. E. Kayl, Anne E. Kayl, 2006, Current opinion in obstetrics & gynecology.

Quantitative Morphology of the Corpus Callosum in Children With Neurofibromatosis and Attention-Deficit Hyperactivity Disorder

B. Moore, J. Slopis, E. Jackson, 2000, Journal of child neurology.

Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy

J. Benge, P. Massman, N. Perrier, 2009, Journal of the International Neuropsychological Society.

Does brain tumor histology influence cognitive function?

C. Meyers, A. E. Kayl, Anne E. Kayl, 2003, Neuro-oncology.